Critical role of HMGA proteins in cancer cell chemoresistance

被引:19
|
作者
D'Angelo, Daniela [1 ]
Mussnich, Paula [1 ]
Arra, Claudio [2 ]
Battista, Sabrina [1 ]
Fusco, Alfredo [1 ,3 ]
机构
[1] Ist Endocrinol & Oncol Sperimentale CNR, Via Pansini 5, I-80131 Naples, Italy
[2] IRCCS, Ist Nazl Studio & Cura Tumori Fdn Giovanni Pascal, Naples, Italy
[3] Univ Napoli Federico II, DMMBM, Via Pansini 5, I-80131 Naples, Italy
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2017年 / 95卷 / 04期
关键词
HMGA; Chemoresistance; DNA repair; Apoptosis; miRNAs; GROUP-A PROTEINS; PHASE-II TRIAL; TRANSGENIC MICE; DRUG-RESISTANCE; UP-REGULATION; CISPLATIN RESISTANCE; MULTIDRUG-RESISTANCE; COLORECTAL-CANCER; CARCINOMA CELLS; DOWN-REGULATION;
D O I
10.1007/s00109-017-1520-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The high-mobility group A (HMGA) proteins are frequently overexpressed in human malignancies and correlate with the presence of metastases and reduced patient survival. Here, we highlight the main studies evidencing a critical role of HMGA in chemoresistance, mainly by activating Akt signaling, impairing p53 activity, and regulating the expression of microRNAs that target genes involved in the susceptibility of cancer cells to antineoplastic agents. Therefore, these studies account for the association of HMGA overexpression with patient poor outcome, indicating the impairment of HMGA as a fascinating perspective for effectively improving cancer therapy.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 50 条
  • [11] The role of membrane transporters in ovarian cancer chemoresistance and prognosis
    Cerovska, Ela
    Elsnerova, Katerina
    Vaclavikova, Radka
    Soucek, Pavel
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (07) : 741 - 753
  • [12] The emerging role of noncoding RNAs in colorectal cancer chemoresistance
    Wei, Ling
    Wang, Xingwu
    Lv, Liyan
    Zheng, Yan
    Zhang, Nasha
    Yang, Ming
    CELLULAR ONCOLOGY, 2019, 42 (06) : 757 - 768
  • [13] Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance
    Console, Lara
    Scalise, Mariafrancesca
    LIFE-BASEL, 2022, 12 (05):
  • [14] The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
    Song, Kaiyang
    Artibani, Mara
    HEALTH SCIENCE REPORTS, 2023, 6 (05)
  • [15] The role of H19 lncRNA in conferring chemoresistance in cancer cells
    Ghafouri-Fard, Soudeh
    Shoorei, Hamed
    Bahroudi, Zahra
    Abak, Atefe
    Taheri, Mohammad
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 138
  • [16] The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
    Fu, Yibo
    Ricciardiello, Francesca
    Yang, Gang
    Qiu, Jiangdong
    Huang, Hua
    Xiao, Jianchun
    Cao, Zhe
    Zhao, Fangyu
    Liu, Yueze
    Luo, Wenhao
    Chen, Guangyu
    You, Lei
    Chiaradonna, Ferdinando
    Zheng, Lianfang
    Zhang, Taiping
    CELLS, 2021, 10 (03) : 1 - 33
  • [17] Autophagy-mediating microRNAs in cancer chemoresistance
    Jing, Yuanming
    Liang, Wenqing
    Liu, Jian
    Zhang, Lin
    Wei, Jianguo
    Yang, Jianhui
    Zhang, Yu
    Huang, Zongliang
    CELL BIOLOGY AND TOXICOLOGY, 2020, 36 (06) : 517 - 536
  • [18] Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer
    Li, Zonglin
    Shu, Xingming
    Liu, Xin
    Li, Qiuyun
    Hu, Yifu
    Jia, Bingbing
    Song, Min
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 3779 - 3788
  • [19] Metastasis and chemoresistance in breast cancer: Crucial function of ZEB1/ 2 proteins
    Doodmani, Seyed Mohammad
    Safari, Mohamad Hosein
    Akbari, Mohammadarian
    Farahani, Najma
    Alimohammadi, Mina
    Aref, Amir Reza
    Tajik, Fatemeh
    Maghsoodlou, Amin
    Daneshi, Salman
    Tabari, Teimour
    Taheriazam, Afshin
    Entezari, Maliheh
    Nabavi, Noushin
    Hashemi, Mehrdad
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 267 : 155838
  • [20] ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
    Tsoumas, Dimitrios
    Nikou, Sofia
    Giannopoulou, Efstathia
    Tsaniras, Spyridon Champeris
    Sirinian, Chaido
    Maroulis, Ioannis
    Taraviras, Stavros
    Zolota, Vassiliki
    Kalofonos, Haralabos P.
    Bravou, Vasiliki
    CANCER GENOMICS & PROTEOMICS, 2018, 15 (02) : 127 - 141